Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 2/20 | 0.32 |
| ▸ | ITGB2 | P05107 | 1/20 | 0.32 |
| ▸ | ICAM1 | P05362 | 1/20 | 0.32 |
| ▸ | ITGAL | P20701 | 1/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
| ▸ | THRB | P10828 | 1/20 | 0.32 |
| ▸ | TSHR | P16473 | 1/20 | 0.32 |
| ▸ | HTT | P42858 | 1/20 | 0.32 |
| ▸ | RECQL | P46063 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21510466 | 0.90 | ESR1 (0.30) | — | |
| SCHEMBL21510271 | 0.90 | LMNA (0.30) | LMNA | |
| SCHEMBL21510255 | 0.89 | HDAC6 (0.38) | LMNAMEN1MAPTKMT2A | |
| SCHEMBL13832913 | 0.88 | PGR (0.36) | LMNAITGB2ICAM1ITGALMEN1 | |
| SCHEMBL13231589 | 0.86 | LMNA (0.39) | LMNAITGB2ICAM1ITGALMEN1 | |
| SCHEMBL13833004 | 0.84 | PGR (0.35) | LMNAITGB2ICAM1ITGALMEN1 | |
| SCHEMBL13833002 | 0.83 | PGR (0.33) | LMNAITGB2ICAM1ITGALMEN1 | |
| SCHEMBL13833016 | 0.82 | ALDH1A1 (0.42) | LMNAITGB2ICAM1ITGALMEN1 | |
| SCHEMBL13832919 | 0.82 | PGR (0.34) | LMNAITGB2ICAM1ITGALMEN1 | |
| SCHEMBL20230677 | 0.82 | HTR6 (0.35) | LMNAITGB2ICAM1ITGALMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20190322623-A1 | COMPOUND, DISPLAY PANEL, AND DISPLAY APPARATUS | WUHAN TIANMA MICRO-ELECTRONICS CO., LTD. (CN) | 2019-10-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190322623-A1 | COMPOUND, DISPLAY PANEL, AND DISPLAY APPARATUS | DRD2, GRIN2D, DRD1 | LMNA 1991/4885ITGB2 85/4885ICAM1 1748/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.